{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:27:45Z","timestamp":1750894065319},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[1999,1,14]],"date-time":"1999-01-14T00:00:00Z","timestamp":916272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1038\/sj.bjc.6690061","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T14:01:11Z","timestamp":1032271271000},"page":"386-392","source":"Crossref","is-referenced-by-count":30,"title":["Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7\/182R-6"],"prefix":"10.1038","volume":"79","author":[{"given":"B L","family":"Jensen","sequence":"first","affiliation":[]},{"given":"J","family":"Skouv","sequence":"additional","affiliation":[]},{"given":"B K","family":"Lundholt","sequence":"additional","affiliation":[]},{"given":"A E","family":"Lykkesfeldt","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[1999,1,14]]},"reference":[{"key":"BF6690061_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1210\/mend-3-1-22","volume":"3","author":"A Berkenstam","year":"1989","unstructured":"Berkenstam, A., Glaumann, H., Martin, M., Gustafsson, J\u00c5 & Norsted, G. (1989). Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells. Mol Endocrinol 3: 22\u201328.","journal-title":"Mol Endocrinol"},{"key":"BF6690061_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0303-7207(90)90201-I","volume":"74","author":"Y Berthois","year":"1990","unstructured":"Berthois, Y., Dong, X. F., Roux-Dossetto, M. & Martin, P. M. (1990). Expression of estrogen receptor and its messenger ribonucleic acid in the MCF-7 cell line: multiparametric analysis of its processing and regulation by estradiol. Mol Cell Endocrinol 74: 11\u201320.","journal-title":"Mol Cell Endocrinol"},{"key":"BF6690061_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0960-0760(94)90072-8","volume":"48","author":"M Borr\u00e1s","year":"1994","unstructured":"Borr\u00e1s, M., Hardy, L., Lempereue, F., El Khissiin, A. H., Legros, N., Gol-Winkler, R. & Leclercq, G. (1994). Estrogen-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol 48: 325\u2013336.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BF6690061_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0960-0760(95)00272-3","volume":"57","author":"M Borr\u00e1s","year":"1996","unstructured":"Borr\u00e1s, M., Laios, I., El Khissiin, A., Seo, H. S., Lempereur, F., Legros, N. & Leclercq, G. (1996). Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 57: 203\u2013213.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BF6690061_CR5","first-page":"1114","volume":"44","author":"P Briand","year":"1984","unstructured":"Briand, P. & Lykkesfeldt, A. E. (1984). Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to grow at low serum concentration. Cancer Res 44: 1114\u20131119.","journal-title":"Cancer Res"},{"key":"BF6690061_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1043-2760(96)00127-0","volume":"7","author":"R Clarke","year":"1996","unstructured":"Clarke, R. & Br\u00fcnner, N. (1996). Acquired estrogen independence and antiestrogen resistance in breast cancer. Estrogen receptor driven phenotypes? Trends Endocrinol Metab 7: 291\u2013301.","journal-title":"Trends Endocrinol Metab"},{"key":"BF6690061_CR7","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1073\/pnas.89.9.4037","volume":"89","author":"S Dauvois","year":"1992","unstructured":"Dauvois, S., Danielian, P. S., White, R. & Parker, M. G. (1992). Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89: 4037\u20134041.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690061_CR8","unstructured":"EORTC Breast Co-operative Group (1980). Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second EORTC workshop, held on 16\u201317 March, 1979, in the Netherlands Cancer Institute. Eur J Cancer 16: 1513\u20131515."},{"key":"BF6690061_CR9","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1210\/endo-129-4-2000","volume":"129","author":"MK Gibson","year":"1991","unstructured":"Gibson, M. K., Nemmers, L. A., Beckman, W. C., Davis, V. L., Curtis, S. W. & Korack, K. S. (1991). The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of ER in uterine tissue. Endocrinology 129: 2000\u20132010.","journal-title":"Endocrinology"},{"key":"BF6690061_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0960-0760(96)00114-8","volume":"59","author":"ME Herman","year":"1996","unstructured":"Herman, M. E. & Katzenellenbogen, B. S. (1996). Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen. J Steroid Biochem Mol Biol 59: 121\u2013134.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BF6690061_CR11","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1016\/S0021-9258(17)34379-X","volume":"253","author":"KB Horwitz","year":"1978","unstructured":"Horwitz, K. B. & McGuire, W. L. (1978). Nuclear mechanisms of estrogen action. J Biol Chem 253: 8185\u20138191.","journal-title":"J Biol Chem"},{"key":"BF6690061_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(95)91156-1","volume":"345","author":"A Howell","year":"1995","unstructured":"Howell, A., DeFriend, D. J., Robertson, J. F. R., Blamey, R. W. & Walton, P. (1995). Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer. Lancet 345: 29\u201330.","journal-title":"Lancet"},{"key":"BF6690061_CR13","first-page":"2547","volume":"57","author":"SM Hyder","year":"1997","unstructured":"Hyder, S. M., Chiappetta, C., Murthy, L. & Stancel, G. M. (1997). Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780. Cancer Res 57: 2547\u20132549.","journal-title":"Cancer Res"},{"key":"BF6690061_CR14","first-page":"3331","volume":"55","author":"SRD Johnston","year":"1995","unstructured":"Johnston, S. R. D., Saccani-Jotti, G., Smith, I. E., Salter, J., Newby, J., Coppen, M., Ebbs, S. R. & Dowsett, M. (1995). Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res 55: 3331\u20133338.","journal-title":"Cancer Res"},{"key":"BF6690061_CR15","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/jnci\/83.20.1434","volume":"83","author":"BS Katzenellenbogen","year":"1991","unstructured":"Katzenellenbogen, B. S. (1991). Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. J Natl Cancer Inst 83: 1434\u20131444.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690061_CR16","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1093\/nar\/19.14.3998","volume":"19","author":"J Laborda","year":"1991","unstructured":"Laborda, J. (1991). 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19: 3998","journal-title":"Nucleic Acids Res"},{"key":"BF6690061_CR17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<1129::AID-IJC31>3.0.CO;2-X","volume":"72","author":"SS Larsen","year":"1997","unstructured":"Larsen, S. S., Madsen, M. W., Jensen, B. L. & Lykkesfeldt, A. E. (1997). Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness. Int J Cancer 72: 1129\u20131136.","journal-title":"Int J Cancer"},{"key":"BF6690061_CR18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1354393","volume":"257","author":"P Liang","year":"1992","unstructured":"Liang, P. & Pardee, A. B. (1992). Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967\u2013970.","journal-title":"Science"},{"key":"BF6690061_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/02841869609083961","volume":"35","author":"AE Lykkesfeldt","year":"1996","unstructured":"Lykkesfeldt, A. E. (1996). Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer. Acta Oncol 35: 9\u201314.","journal-title":"Acta Oncol"},{"key":"BF6690061_CR20","first-page":"1587","volume":"54","author":"AE Lykkesfeldt","year":"1994","unstructured":"Lykkesfeldt, A. E., Madsen, M. W. & Briand, P. (1994). Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7\/TAMR-1. Cancer Res 54: 1587\u20131595.","journal-title":"Cancer Res"},{"key":"BF6690061_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/ijc.2910610417","volume":"61","author":"AE Lykkesfeldt","year":"1995","unstructured":"Lykkesfeldt, A. E., Larsen, S. S. & Briand, P. (1995). Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment. Int J Cancer 61: 529\u2013534.","journal-title":"Int J Cancer"},{"key":"BF6690061_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0303-7207(95)03503-Y","volume":"109","author":"MW Madsen","year":"1995","unstructured":"Madsen, M. W., Reiter, B. E. & Lykkesfeldt, A. E. (1995). Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7\/TAMR\/TAMR-1 compared to the parental MCF-7 cell line. Mol Cell Endocrinol 109: 197\u2013207.","journal-title":"Mol Cell Endocrinol"},{"key":"BF6690061_CR23","first-page":"2918","volume":"80","author":"S Masamura","year":"1995","unstructured":"Masamura, S., Santner, S. J., Heitjan, D. F. & Santen, R. J. (1995). Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J Clin Endocrinol Metab 80: 2918\u20132925.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF6690061_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0305-7372(78)80017-6","volume":"5","author":"H Mouridsen","year":"1978","unstructured":"Mouridsen, H., Palshof, T., Patterson, J. & Battersby, L. (1978). Tamoxifen in advanced breast cancer. Cancer Treat Rev 5: 131\u2013141.","journal-title":"Cancer Treat Rev"},{"key":"BF6690061_CR25","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U","volume":"46","author":"CK Osborne","year":"1980","unstructured":"Osborne, C. K., Yochmowitz, M. G., Knight, W. A. & McGuire, W. L. (1980). The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884\u20132888.","journal-title":"Cancer"},{"key":"BF6690061_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/jnci\/87.10.746","volume":"87","author":"CK Osborne","year":"1995","unstructured":"Osborne, C. K., Coronado-Heinsohn, E. B., Hilsenbeck, S. G., McCue, B. L., Wakeling, A. E., McClelland, R. A., Manning, D. L. & Nicholson, R. I. (1995). Comparison of the effects of pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. J Natl Cancer Inst 87: 746\u2013750.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690061_CR27","first-page":"2321","volume":"56","author":"JJ Pink","year":"1996","unstructured":"Pink, J. J. & Jordan, V. C. (1996). Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 56: 2321\u20132330.","journal-title":"Cancer Res"},{"key":"BF6690061_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/bjc.1996.2","volume":"73","author":"JFR Robertson","year":"1996","unstructured":"Robertson, J. F. R. (1996). Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer 73: 5\u201312.","journal-title":"Br J Cancer"},{"key":"BF6690061_CR29","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1210\/mend-2-12-1157","volume":"2","author":"M Saceda","year":"1988","unstructured":"Saceda, M., Lippman, M. E., Chambon, P., Lindsey, R. L., Ponglikitmongkol, M., Puente, M. & Martin, M. B. (1988). Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2: 1157\u20131162.","journal-title":"Mol Endocrinol"},{"key":"BF6690061_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0092-8674(89)90031-7","volume":"59","author":"L Tora","year":"1989","unstructured":"Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E. & Chambon, P. (1989). The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59: 477\u2013487.","journal-title":"Cell"},{"key":"BF6690061_CR31","first-page":"1474","volume":"8","author":"T van Agthoven","year":"1994","unstructured":"van Agthoven, T., van Agthoven, T. L. A., Dekker, A., Foekens, J. A. & Dorssers, L. C. J. (1994). Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations. Mol Endocrinol 8: 1474\u20131483.","journal-title":"Mol Endocrinol"},{"key":"BF6690061_CR32","first-page":"3867","volume":"51","author":"AE Wakeling","year":"1991","unstructured":"Wakeling, A. E., Dukes, M. & Bowler, J. (1991). A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867\u20133873.","journal-title":"Cancer Res"},{"key":"BF6690061_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0960-0760(93)90063-3","volume":"47","author":"AE Wakeling","year":"1993","unstructured":"Wakeling, A. E. (1993). Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens?. J Steroid Biochem Mol Biol 47: 107\u2013111.","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690061","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:49:59Z","timestamp":1684414199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1,14]]},"references-count":33,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["BF6690061"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690061","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1,14]]}}}